Get the Stockscreener App
61.97
1.37%
0.84
After Hours:
61.97
Conmed Corp stock is traded at $61.97, with a volume of 471.19K.
It is up +1.37% in the last 24 hours and down -9.89% over the past month.
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
See More
Previous Close:
$61.13
Open:
$61.13
24h Volume:
471.19K
Relative Volume:
1.13
Market Cap:
$1.92B
Revenue:
$1.29B
Net Income/Loss:
$131.74M
P/E Ratio:
14.72
EPS:
4.21
Net Cash Flow:
$166.13M
1W Performance:
-1.87%
1M Performance:
-9.89%
6M Performance:
-13.87%
1Y Performance:
-23.30%
1-Day Range:
$61.13
$63.04
1-Week Range:
$59.50
$63.88
52-Week Range:
$59.50
$86.96
Conmed Corp Stock (CNMD) Company Profile
Name
Conmed Corp
Sector
Industry
Phone
727-214-2974
Address
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
61.97 | 1.92B | 1.29B | 131.74M | 166.13M | 4.21 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-01-24 | Reiterated | Needham | Buy |
| May-22-23 | Initiated | CL King | Buy |
| Mar-27-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-21-23 | Initiated | Wells Fargo | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Oct-06-21 | Upgrade | Needham | Hold → Buy |
| Jul-15-21 | Initiated | UBS | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| Nov-26-19 | Downgrade | Needham | Buy → Hold |
| Nov-12-19 | Initiated | JP Morgan | Overweight |
| Oct-31-19 | Reiterated | Needham | Buy |
| Oct-04-19 | Reiterated | Needham | Buy |
| Aug-22-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Apr-18-19 | Initiated | Stifel | Buy |
| Apr-16-19 | Reiterated | Needham | Buy |
| Jan-23-19 | Reiterated | Needham | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Aug-07-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Apr-26-18 | Reiterated | Needham | Buy |
| Feb-01-18 | Reiterated | Needham | Buy |
| Jul-27-17 | Reiterated | Needham | Buy |
| Apr-27-17 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-27-17 | Reiterated | Needham | Buy |
| Nov-18-16 | Reiterated | Needham | Buy |
| Jul-28-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-28-16 | Reiterated | Needham | Buy |
| Oct-22-15 | Reiterated | Northland Capital | Market Perform |
View All
Conmed Corp Stock (CNMD) Latest News
CONMED (NYSE:CNMD) Sets New 52-Week LowWhat's Next? - MarketBeat
Olympiad Research LP Makes New $340,000 Investment in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Co. (NYSE:CNMD) Shares Purchased by Principal Financial Group Inc. - MarketBeat
Allspring Global Investments Holdings LLC Grows Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Conmed Corporation Faces Rising Business Risks Amid Global Supply Chain Challenges - TipRanks
CONMED Corp SEC 10-K Report - TradingView
CONMED Co. (NYSE:CNMD) Short Interest Update - MarketBeat
Conmed's chief information officer sells $16,796 in common stock - MSN
Yousif Capital Management LLC Sells 285 Shares of CONMED Co. (NYSE:CNMD) - Defense World
CONMED Co. (NYSE:CNMD) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Conmed's chief information officer sells $16,796 in common stock By Investing.com - Investing.com Australia
CONMED Co. (NYSE:CNMD) Shares Sold by Choreo LLC - Defense World
abrdn plc Has $9.40 Million Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Prepare Yourself for Liftoff: Conmed Corp (CNMD) - SETE News
CONMED (NYSE:CNMD) Given New $91.00 Price Target at Needham & Company LLC - MarketBeat
CONMED (NYSE:CNMD) Price Target Lowered to $70.00 at Wells Fargo & Company - MarketBeat
Wound Closure Market Size to Hit USD 26.63 Billion by 2032, Growing at a CAGR of 6.47% - GlobeNewswire Inc.
CONMED (NYSE:CNMD) Downgraded to "Neutral" Rating by JPMorgan Chase & Co. - MarketBeat
CONMED (NYSE:CNMD) Given New $75.00 Price Target at Stifel Nicolaus - MarketBeat
CONMED (NYSE:CNMD) Issues Quarterly Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
CONMED (NYSE:CNMD) Updates FY 2025 Earnings Guidance - MarketBeat
CONMED Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Yahoo Finance
Wells Fargo & Company Issues Pessimistic Forecast for CONMED (NYSE:CNMD) Stock Price - Defense World
Stifel Nicolaus Forecasts Strong Price Appreciation for CONMED (NYSE:CNMD) Stock - Defense World
Market Resilience: Conmed Corp (CNMD) Finishes Weak at 67.36, Down -8.97 - The Dwinnex
CONMED (NYSE:CNMD) Shares Gap Down After Analyst Downgrade - MarketBeat
Taking a look at what insiders are doing to gauge the Conmed Corp (CNMD)’s direction - Knox Daily
Behind Conmed Corp’s 52-Week Range: Uncovering Opportunities for Investors - The InvestChronicle
Needham & Company LLC Issues Pessimistic Forecast for CONMED (NYSE:CNMD) Stock Price - Armenian Reporter
Breaking Down Conmed: 4 Analysts Share Their Views - Benzinga
This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Needham cuts CONMED stock target to $91, maintains Buy rating - Investing.com
CONMED Corporation (NYSE:CNMD) Q4 2024 Earnings Call Transcript - Insider Monkey
CONMED Beats Analysts' Q4 Expectations Despite Full-Year Forecast ShortfallNews and Statistics - IndexBox, Inc.
These Analysts Slash Their Forecasts On Conmed After Q4 Results - Benzinga
JPMorgan cuts CONMED stock rating, lowers price target to $70 - Investing.com
Conmed: Q4 Earnings Snapshot - The Advocate
Conmed Corp (CNMD) Q4 2024 Earnings Call Highlights: Strong Growth in General Surgery and ... - Yahoo Finance
Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings - MSN
CONMED earnings beat by $0.13, revenue topped estimates - Investing.com
Conmed Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Conmed (CNMD) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops By Stock Story - Investing.com Canada
Conmed Q4 Earnings Assessment - Benzinga
Conmed Q4 Earnings Summary & Key Takeaways - Benzinga
Insights into Conmed Q4 Earnings - Benzinga
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops - Yahoo Finance
Conmed Corp Stock (CNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):